• SENSEX
    NIFTY 50

Covishield, Covaxin generate half antibodies against B.1.617 COVID-19 variant compared to original strain: Report

Updated : May 15, 2021 19:30:37 IST

Since January, the scientists at the ICMR-National Institute of Virology have been collecting samples from the COVID-positive individuals and testing them for prominent variants.
The two vaccines were designed on the blueprint of the B1 virus variant that became the dominant strain in India by last April.
Covishield, Covaxin generate half antibodies against B.1.617 COVID-19 variant compared to original strain: Report
Published : May 15, 2021 06:57 PM IST

You May Also Like

Live TV

recommended for you

Advertisement